From molecule to clinic and community for neurodegeneration: Research to bridge translational gaps

Journal of Alzheimer's Disease

Volumn 33, Issue SUPPL. 1, 2013, Pages

  Brayne, Carol ^a   Barker, Roger A ^b   Harold, Denise ^c   Ince, Paul G ^d   Savva, George M ^e   Williams, Julie ^c   Williams Gray, Caroline H ^b   Wharton, Stephen B ^d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Alzheimer's disease; dementia; epidemiology; genetics; pathology

Indexed keywords

ALPHA SYNUCLEIN; APOLIPOPROTEIN E; CD2 ASSOCIATED PROTEIN; CLATHRIN ASSEMBLY PROTEIN; CLUSTERIN; COMPLEMENT COMPONENT C3B RECEPTOR; EPHRIN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOCHONDRIAL DNA; TAU PROTEIN;

ADAPTIVE IMMUNITY; AGING; ALLELE; ALZHEIMER DISEASE; COGNITION; DISEASE PREDISPOSITION; GENE CLUSTER; GENE LOCUS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENOTYPE; HAPLOTYPE; HEALTH CARE PLANNING; HUMAN; INNATE IMMUNITY; LINKAGE ANALYSIS; NERVE DEGENERATION; NEUROPATHOLOGY; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; WHITE MATTER LESION;

EID: 84872517145     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-129006     Document Type: Review

References (75)

1. Grupe A, Abraham R, Li Y, Rowland C, Hollingworth P, Morgan A, Jehu L, Segurado R, Stone D, Schadt E, Karnoub M, Nowotny P, Tacey K, Catanese J, Sninsky J, Brayne C, Rubinsztein D, Gill M, Lawlor B, Lovestone S, Holmans P, O'Donovan M, Morris JC, Thal L, Goate A, Owen MJ, Williams J (2007) Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Hum Mol Genet 16, 865-873
2. Figgins JA, Minster RL, Demirci FY, Dekosky ST, Kamboh MI (2009) Association studies of 22 candidate SNPs with lateonset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 150B, 520-526
3. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K,Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, FoxN, Rossor M, Collinge J, MaierW, Jessen F, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van BroeckhovenC,Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N,Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J (2009) Genome-wide association study identifies variants at LU and PICALM associated with Alzheimer's disease. Nat Genet 41, 1088-1093
4. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N,Younkin SG, CruchagaC, Kauwe JS,Nowotny P, Kramer P, Hardy J, Huentelman MJ, Myers AJ, Barmada MM, Demirci FY, Baldwin CT, Green RC, Rogaeva E, St George-Hyslop P, Arnold SE, Barber R, Beach T, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Carlson CS, Carney RM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cotman CW, Cummings JL, DeCarli C, DeKosky ST, Diaz-Arrastia R, Dick M, Dickson DW, Ellis WG, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Giordani B, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Johnson N, Karlawish J, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Lah JJ, Levey AI, Lieberman AP, Lopez OL, Mack WJ, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Parisi JE, Perl DP, Peskind E, Petersen RC, Poon WW, Quinn JF, Rajbhandary RA, Raskind M, ReisbergB, Ringman JM, Roberson ED, Rosenberg RN, Sano M, Schneider LS, Seeley W, Shelanski ML, Slifer MA, Smith CD, Sonnen JA, Spina S, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA,Williamson J,Woltjer RL, Cantwell LB, Dombroski BA, Beekly D, Lunetta KL, Martin ER, Kamboh MI, Saykin AJ, Reiman EM, BennettDA,Morris JC, Montine TJ, GoateAM,Blacker D, TsuangDW, Hakonarson H,Kukull WA, Foroud TM, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 43, 436-441
5. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM,Lendon C, Dufouil C, Jaillard C, LeveillardT, AlvarezV, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M, Amouyel P (2009) Genome-wide association study identifies variants atCLUandCR1associated with Alzheimer's disease. Nat Genet 41, 1094-1099
6. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, Bis JC, Smith AV, Carassquillo MM, Lambert JC, Harold D, Schrijvers EM, Ramirez-Lorca R, Debette S, Longstreth WT Jr, Janssens AC, Pankratz VS, Dartigues JF, Hollingworth P, Aspelund T, Hernandez I, Beiser A, Kuller LH, Koudstaal PJ, Dickson DW, Tzourio C, Abraham R, Antunez C, Du Y, Rotter JI, Aulchenko YS, Harris TB, Petersen RC, Berr C, Owen MJ, Lopez-Arrieta J, Varadarajan BN, Becker JT, Rivadeneira F, Nalls MA, Graff-Radford NR, Campion D, Auerbach S, Rice K, Hofman A, Jonsson PV, Schmidt H, Lathrop M, Mosley TH, Au R, Psaty BM, Uitterlinden AG, Farrer LA, Lumley T, Ruiz A, Williams J, Amouyel P, Younkin SG, Wolf PA, Launer LJ, Lopez OL, van Duijn CM, Breteler MM (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303, 1832-1840
7. Carrasquillo MM, Belbin O, Hunter TA,Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG (2010) Replication of CLU, CR1, and PICALM associations with alzheimer disease. Arch Neurol 67, 961-964
8. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D,Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H, Warden D, Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ER, Hardy J, Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Ruther E, Schurmann B, Heun R, Kolsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Gallacher J, Hull M, Rujescu D, Giegling I, GoateAM,Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, van Duijn CM, Breteler MM, Ikram MA, DeStefano AL, Fitzpatrick AL, Lopez O, Launer LJ, Seshadri S, Berr C, Campion D, Epelbaum J, Dartigues JF, Tzourio C, Alperovitch A, Lathrop M, Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snaedal J, Bjornsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossu P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA, Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O'Donovan M, Amouyel P, Williams J (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43, 429-435
9. Hu X, Pickering E, Liu YC, Hall S, Fournier H, Katz E, Dechairo B, John S, Van Eerdewegh P, Soares H (2011) Meta-Analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease. PLoS One 6, e16616
10. Hollingworth P, Sweet R, Sims R, Harold D, Russo G, Abraham R, Stretton A, Jones N, Gerrish A, Chapman J, Ivanov D, Moskvina V, Lovestone S, Priotsi P, Lupton M, Brayne C, Gill M, Lawlor B, Lynch A, Craig D, McGuinness B, Johnston J, Holmes C, Livingston G, Bass NJ, Gurling H, McQuillin A, Holmans P, Jones L, Devlin B, Klei L, Barmada MM, Demirci FY, Dekosky ST, Lopez OL, Passmore P, Owen MJ, O'Donovan MC, Mayeux R, Kamboh MI, Williams J (2011) Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol Psychiatry, doi: 10.1038/mp.2011.125
11. Jones L, Holmans PA, Hamshere ML, Harold D, Moskvina V, Ivanov D, Pocklington A, Abraham R, Hollingworth P, Sims R, Gerrish A, Pahwa JS, Jones N, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, Heun R, Kolsch H, van den Bussche H, Heuser I, Peters O, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Ruther E, Carrasquillo MM, Pankratz VS, Younkin SG, Hardy J, O'Donovan MC, Owen MJ, Williams J (2010) Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One 5, e13950
12. Hudson G, Sims R, Harold D, Chapman J, Hollingworth P, Gerrish A, Russo G, Hamshere M, Moskvina V, Jones N, Thomas C, Stretton A, Holmans PA, O'Donovan MC, Owen MJ, Williams J, Chinnery PF (2012) No consistent evidence for association between mtDNA variants and Alzheimer disease. Neurology 78, 1038-1042
13. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P (2003) Prevalence and characteristics of dementia in Parkinson disease: An 8-Year prospective study. Arch Neurol 60, 387-392
14. Foltynie T, Brayne CE, Robbins TW, Barker RA (2004) The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 127, 550-560
15. Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ, Barker RA (2009) The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 132, 2958-2969
16. Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA (2007) Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 130, 1787-1798
17. Williams-Gray CH, Goris A, Saiki M, Foltynie T, Compston DA, Sawcer SJ, Barker RA (2009) Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease. J Neurol 256, 493-498
18. Goris A, Williams-Gray CH, Clark GR, Foltynie T, Lewis SJ, Brown J, Ban M, Spillantini MG, Compston A, Burn DJ, Chinnery PF, Barker RA, Sawcer SJ (2007) Tau and alphasynuclein in susceptibility to, and dementia in, Parkinson's disease. Ann Neurol 62, 145-153
19. Williams-Gray CH, Hampshire A, Barker RA, Owen AM (2008) Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype. Brain 131, 397-408
20. Williams-Gray CH, Hampshire A, Robbins TW, Owen AM, Barker RA (2007) Catechol O-Methyltransferase val158met genotype influences frontoparietal activity during planning in patients with Parkinson's disease. J Neurosci 27, 4832-4838
21. Compta Y, Parkkinen L, O'Sullivan SS, Vandrovcova J, Holton JL, Collins C, Lashley T, Kallis C, Williams DR, de Silva R, Lees AJ, Revesz T (2011) Lewy- And Alzheimer-Type pathologies in Parkinson's disease dementia: Which is more important? Brain 134, 1493-1505
22. Evans JR, Mason SL,Williams-Gray CH, Foltynie T, Brayne C, Robbins TW, Barker RA (2011) The natural history of treated Parkinson's disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry 82, 1112-1118
23. Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G (2009) Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest study. Neurology 72, 1121-1126
24. Zaccai J, Ince P, Brayne C (2006) Population-based neuropathological studies of dementia: Design, methods and areas of investigation-A systematic review. BMC Neurol 6, 2
25. Schoenmaker N, Van Gool W (2004) The age gap between patients in clinical studies and in the general population: A pitfall for dementia research. Lancet Neurol 3, 627-630
26. MRC-CFAS (2001) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357, 169-175
27. Schneider J, Arvanitakis Z, Bang W, Bennett D (2007) Mixed brain pathologies account for most dementia cases in community-Dwelling older persons. Neurology 69, 2193-2194
28. Berg L, McKeel D, Miller J, Storandt M, Rubin E, Morris J, Baty J, Coats M, Norton J, Goate A, Price J, Gearing M, Mirra S, SaundersA(1998) Clinicopathologic studies in cognitively healthy aging and Alzheimer disease. Relation of histologic markers to dementia severity, age, sex and apolipoprotein E genotype. Arch Neurol 55, 326-335
29. Mann D, Yates P, Marcyniuk B (1985) Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age. J Neurol Sci 69, 139-159
30. Prohovnic I, Perl D, Davis K, Libow L, Lesser G, Haroutunian V (2006) Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease. Neurology 66, 49-55
31. Bennett D, Schneider J, Arvanitakis Z, Kelly J, Aggarwal N, Shah R, Wilson R (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66, 1837-1844
32. Haroutunian V, Schnaider-Beeri M, Schmeidler J, Wysocki M, Purohit D, Perl D, Libow L, Lesser G, Maroukian M, HT G (2008) Role of the neuropathology of Alzheimer disease in dementia in the oldest old. Arch Neurol 65, 1211-1217
33. Savva G, Wharton S, Ince P, Forster G, Matthews F, Brayne C (2009) For the medical research council cognitive function and ageing study. Age, neuropathology and dementia. N Eng J Med 360, 2302-2309
34. Ewbank D, Arnold S (2009) Cool with plaques and tangles. N Eng J Med 360, 2357-2359
35. Terry R, Masliah E, Salmon D, Butters N, DeTeresa R, Hill R, Hansen L, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580
36. Fotuhi M, Hachinski V, PJ W (2009) Changing perspectives regarding late-Life dementia. Nat Rev Neurol 5, 649-658
37. Fernando M, Simpson J, Matthews F, Brayne C, Lewis C, Barber R, Kalaria R, Forster G, Esteves F,Wharton S, ShawP, O'Brien J, Ince P (2006) White matter lesions in an unselected cohort of the elderly: Molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 37, 1391-1398
38. Launer L, Berger K, Breteler M, Dufouil C, Fuhrer R, Giampaoli S, Nilsson L, Pajak A, de Ridder M, van Dijk E, Sans S, Schmidt R, Hofman A (2006) Regional variability in the prevalence of cerebral white matter lesions: An MRI study in 9 European countries (CASCADE). Neuroepidemiology 26, 23-29
39. De Leeuw F-E, De Groot J, Achten E, Oudkerk M, Ramos L, Heijboer R, Hofman A, Jolles J,Van Gijn J, BretelerM(2001) Prevalence of cerebral white matter lesions in elderly people: A population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiat 70, 9-14
40. Srikanth V, Beare R, Blizzard L, Phan T, Stapleton J, Chen J, Callisaya M, Martin K, Reutens D (2009) Cerebral white matter lesions, gait, and the risk of incident falls.Aprospective population-based study. Stroke 40, 175-180
41. Ikram M, Luijendijk H, Vernooij M, Horfman A, NiessenW, van der Lugt A, Tiemeier H, BretelerM(2010) Vascular brain disease and depression in the elderly. Epidemiology 21, 78-81
42. Inaba M, White L, Bell C, Chen R, Petrovich H, Launer L, Abbott R, Ross G, Masaki K (2011) White matter lesions on brain magnetic resonance imaging scan and 5-Year cognitive decline: The Honolulu-Asia Aging Study. J Am Geriatr Soc 59, 1484-1489
43. Breteler M, Van Swieten J, Bots M, Grobbee D, Claus J, Van Den Hout J,Van Harskamp F,Tanghe H, De Jong P,Van Gijn J, Hofman A (1994) Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study. Neurology 44, 1246-1252
44. Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, Perry R, O'Brien J (1999) White matter lesions on magentic resonance imaging in dementia wth Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiat 67, 66-72
45. Prins N, van Dijk E, den Heijer T, Vermeer S, Jolles J, Koudstaal P, Hofman A, Breteler M (2005) Cerebral small-Vessel disease and decline in information processing speed, executive function and memory. Brain 128, 2034-2041
46. Debette S, Markus H (2010) The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: Systematic review and meta-Analysis. Br Med J 341, c3666
47. Fernando M, Ince P (2004) Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci 226, 13-17
48. Ovbiagele B, Saver J (2006) Cerebral white matter hyperintensities on MRI: Current concepts and therapeutic implications. Cerebrovasc Dis 22, 83-90
49. Raiha I, Tarvonen S, Kurki T, Rajala T, Sourander L (1993) Relationship between vascular factors and white matter low attenuation of the brain. Acta Neurol Scand 87, 286-289
50. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L-A, Nilsson L, Persson G, Oden A, Svanborg A (1996) 15-Year longitudinal study of blood pressure and dementia. Lancet 347, 1141-1145
51. Fernando M, O'Brien J, Perry R, English P, Forster G, McMeekin W, Slade J, Golkhar A, Matthews F, Barber R, Kalaria R, Ince P (2004) Comparison of the pathology of cerebral white matter with post-Mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol 30, 385-395
52. Simpson J, Ince P, Higham C, Gelsthorpe C, Fernando M, Matthews F, Forster G, O'Brien J, Barber R, Kalaria R, Brayne C, Shaw P, Stoeber K, Williams G, Lewis C, Wharton S (2007) On behalf of the MRC Cognitive Function and Ageing Neuropathology Study Group. Microglial activation in white matter lesions and nonlesional white matter of ageing brains. Neuropathol Appl Neurobiol 33, 670-683
53. Simpson J, El-Sayad O, Wharton S, Heath P, Holden H, Fernando M, Matthews F, Forster G, O'Brien J, Barber R, Kalaria R, Brayne C, Shaw P, Lewis C, Ince P (2009) Medical Research Council Cognitive Function and Ageing Study Neuropathology Group. MicroarrayRNAexpression analysis of cerebral white matter lesions reveals changes in multiple functional pathways. Stroke 40, 369-375
54. Simpson JE, Fernando M, Clark L, Ince P, Matthews F, Forster G, O'Brien J, Barber R, Kalaria R, Brayne C, Shaw P, Lewis C, Wharton S (2007) White matter lesions in an unselected cohort of the elderly: Astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol 33, 410-419
55. Tomimoto H, Akiguchi I, Suenaga T, Nishimura M,Wakita H, Nakamura S, Kimura J (1996) Alterations of the blood-brain barrier and glial cells in white-Matter lesions in cerebrovascular and Alzheimer's disease patients. Stroke 27, 2069-2074
56. Del Bigio M, Deck J, Davidson G (2000) Glial swelling with eosinophilia in human post-Mortem brains: A change indicative of plasma extravasation. Acta Neuropathol 100, 688-694
57. Viggars A, Wharton S, Simpson J, Matthews F, Brayne C, Savva G, Garwood C, Drew D, Shaw P, Ince P (2011) Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-Type pathology: A study in the MRC-CFASpopulation neuropathology cohort. Neurosci Lett 505, 25-30
58. Weller R, Djuanda E, Yow H-Y, Carare R (2009) Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol 117, 1-14
59. Wallin A, Fladby T (2010) Do white matter hyperintensities on MRI matter clinically? Br Med J 341, 259-260
60. Rosenbery G (2009) Inflammation and white matter damage in vascular cognitive impairment. Stroke 40(SUPPL1), S20-S23
61. Zaccai J, Brayne C, McKeith I, Matthews F, Ince P (2008) MRC Cognitive Function, Ageing Neuropathology Study. Patterns and stages of alpha-Synucleinopathy: Relevance in a population-based cohort. Neurology 70, 1042-1048
62. Croisier E, MRes D, Deprez K, Goldring K, Dexter D, Pearce R, Graeber M, Roncaroli F (2006) Comparative study of commercially available anti-Synuclein antibodies. Neuropathol Appl Neurobiol 32, 351-356
63. Alafuzoff I, Parkkinen L, Al-Saraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Ferrer I, Gelpi E, Gentleman S, Giacconi G, KamphorstW, King A,Korkolopoulou P,Kovacs G, Larionov S, Meyronet D, Monoranu C, Morris J, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Streichenberger N, Thal D, Kretschmar H (2008) Assessment of alpha-Synuclein pathology: A study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol 67, 125-143
64. Matthews F, Brayne C, Lowe J, McKeith I, Wharton S, Ince P (2009) Epidemiological pathology of dementia: Attributablerisks at death in the MRC Cognitive Function and Ageing Study. PLOS Med 6, e1000180
65. McKeith I, Dickson D, Lowe J, Emre M, O'Brien J, Feldman H, Cummings J, Duda J, Lippa C, Perry E, Aarsland D, Arai H, Ballard C, Boeve B, Burn D, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz C, Gomez-Tortosa E, Halliday G, Hansen L, Hardy J, IwatsuboT, Kalaria R, Kaufer D,Kenny R, Korczyn A, Kosaka K, Lee V, Lees A, Litvan I, Londos E, Lopez O, Minoshima S, Mizuno Y, Molina J, Mukaetova-Ladinska E, Pasquier F, Perry R, Schultz J, Trojanowski J, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies. Third report of the DLB Consortium. Neurology 65, 1863-1872
66. Hamilton R (2000) Lewy bodies in Alzheimer disease: A neuropathological review of 145 cases using -Synuclein immunohistochemistry. Brain Pathol 10, 378-384
67. Braak H, Del Tredici K, Rub U, de Vos R, Jansen-Steur E, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. . Neurobiol Aging 24, 197-211
68. del Tredici K, Rub U, De Vos R, Bohl J, Braak H (2002) Where does parkinson disease pathology being in the brain. J Neuropathol Exp Neurol 61, 413-426
69. Hawkes C, Del Tredici K, Braak H (2007) Review: Parkinson's disease: A dual-hit hypothesis. Neuropathol Appl Neurobiol 33, 599-614
70. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259
71. Lace G, Savva G, Forster G, de Silva R, Brayne C, Matthews F, Barclay J, Dakin L, Ince P, Wharton S (2009) On behalf of MRC-CFAS. Hippocampal tau pathology is related to neuroanatomical connections: An ageing population-based study. Brain 132, 1324-1334
72. de Calignon A, Polydoro M, Suarez-Calvet M, William C, Adamowicz D, Kopeikina K, Pitstick R, Sahara N, Ashe K, Carlson G, Spires-Jones T, Hyman B (2012) Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73, 685-697
73. Frost B, Diamond M (2010) Prion-Like mechanisms in neurodegenerative diseases. Nat Rev Neurosci 11, 155-159
74. Kalaitzakis M, Graeber M, Gentleman S, PearceR(2008) The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: A critical analysis of a-Synuclein staging. Neuropathol Appl Neurobiol 34, 284-295
75. Parkinnen L, Pirttila T, Alafuzoff I (2008) Applicability of current staging/categorization of a-Synuclein pathology and their clinical relevance. Acta Neuropathol 115, 399-407